ArticlePolymers2021
New Approach for Preparing In Vitro Bioactive Scaffold Consisted of Ag-Doped Hydroxyapatite + Polyvinyltrimethoxysilane.
Article in Polymers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 17 citations in OpenAlex.
- Different solvents and organic modifiers for the control of crystallographic parameters in nano-crystallite hydroxyapatite for amplification of photocatalytic activity.Nanoscale advances · 2024Article
- Article
- Double-Reinforced Fish Gelatin Composite Scaffolds for Osteochondral Substitutes.Materials (Basel, Switzerland) · 2023Article
- Biocompatible Piezoelectric PVDF/HA/AgNOSensors (Basel, Switzerland) · 2022Article
- Nanocomposite Based on HA/PVTMS/ClSensors (Basel, Switzerland) · 2022Article
- Effects of 5 wt.% Polycaprolactone, Polyhydroxybutyrate and Polyvinyltrimethoxysilane on the Properties of Ag/Zn/Mg Alloy.Materials (Basel, Switzerland) · 2022Article
- New Horizons for Hydroxyapatite Supported by DXA Assessment-A Preliminary Study.Materials (Basel, Switzerland) · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 2 countries.
Funding
Abstract
Recently, researchers have focused on the biocompatibility and mechanical properties of highly porous structures of biomaterials products. Porous composites are a new category of bioengineering that possess excellent functional and structural properties. In this study, the physical and mechanical properties of prepared doped silver (Ag)-hydroxyapatite (HA) by the mechanochemical and spark plasma sintering (SPS) methods were investigated. The influence of dopant on phase formation, structural properties, mechanical properties and morphological characteristics was investigated. Furthermore, in this case, as a new approach to produce a porous scaffold with an average size of >100 µm, the hair band was used as a mold. According to the Monshi-Scherrer method, the crystal size of scaffold was calculated 38 ± 2 nm and this value was in the good agreement with average value from transmission electron microscopy (TEM) analysis. In addition, the stress-strain compression test of scaffold was considered, and the maximum value of compressive strength was recorded ~15.71 MPa. Taking into account the XRD, TEM, Fourier-transform infrared (FTIR), scanning electron microscope (SEM) and energy dispersive X-Ray analysis (EDAX) analysis, the prepared scaffold was bioactive and the effects of doped Ag-HA and the use of polyvinyltrimethoxysilane (PVTMS) as an additive were desirable. The results showed that the effect of thermal treatment on composed of Ag and HA were impressive while no change in transformation was observed at 850 °C. In addition, PVTMS plays an important role as an additive for preventing the decomposition and creating open-microporous in the scaffold that these porosities can be helpful for increasing bioactivity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.